PIETRO RONDINELLI: Open Payments
NPI 1831408632 · SOUTH WINDSOR, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,186 in 61 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $892 · 2025 $2,186
Food & beverage: $1,535Travel & lodging: $556Education: $94
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 5 | $917 |
| Aimmune Therapeutics, Inc. | 8 | $254 |
| ABBVIE INC. | 12 | $236 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $156 |
| Janssen Biotech, Inc. | 6 | $149 |
| Ardelyx, Inc. | 8 | $141 |
| Phathom Pharmaceuticals, Inc. | 5 | $65 |
| Madrigal Pharmaceuticals | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Gilead Sciences, Inc. | 2 | $42 |
Products named: General - Therapies, ZENPEP, TREMFYA, IBSRELA, LINZESS, ENTYVIO, VOQUEZNA, REZDIFFRA.
Industry payments across CT — which companies pay providers there.
